LGMD2I in a North American population

Area of Science:

• Genetics
• Neuromuscular Disorders
• Molecular Biology

Background:

• Mutations in the FKRP gene exhibit diverse clinical presentations, from severe congenital muscular dystrophies to limb-girdle muscular dystrophy type 2I (LGMD2I).
• Understanding the genetic basis and phenotypic variability of FKRP-related muscular dystrophies is crucial for accurate diagnosis and patient management.

Purpose of the Study:

• To investigate the frequency and clinical spectrum of FKRP gene mutations in patients presenting with limb-girdle muscular dystrophy (LGMD).
• To assess the diagnostic significance of FKRP mutations in LGMD patients within specific populations.

Main Methods:

• Screening of the FKRP gene was performed in two patient cohorts comprising a total of 87 individuals with an LGMD phenotype.
• Genetic analysis focused on identifying mutations within the FKRP gene and correlating them with clinical manifestations.

Main Results:

• The FKRP mutation c.826C>A, p.L276I was identified in six patients, with a compound heterozygote mutation found in a seventh patient.
• Six patients presented with a mild LGMD2I phenotype, clinically resembling Becker muscular dystrophy.
• One patient exhibited early-onset disease (before age 3), suggesting a potentially more severe disease course.

Conclusions:

• The findings indicate that limb-girdle muscular dystrophy type 2I (LGMD2I) may be a common diagnosis in certain North American populations.
• Early consideration of LGMD2I is recommended during the diagnostic workup for patients with limb-girdle muscular dystrophy.